CLINICAL_TRIALS
trial_result
· 2025-08-01
Clinical Trial Update: Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder [Phase 2]
Summary
Phase 2 trial evaluating cannabidiol for craving reduction and relapse prevention in opioid use disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Opioid-use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-08-01